Clinical Trial Update: Trial on the Efficacy of Tegaderm Chlorhexidine Gluconate (CHG) in Reducing Catheter Related Bloodstream Infections [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Tegaderm CHG dressing for reducing catheter-related bloodstream infections, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catheter-related Bloodstream Infection

Drugs mentioned

• Tegaderm CHG (chlorhexidine gluconate-containing medical dressing)

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Catheterization, Infection | Phase 4 | Status: UNKNOWN